UK MHRA certification Awarded to dnata

UK MHRA Certification Awarded to dnata

UK-based global air services provider dnata was recently awarded certification by the UK Medicines and Healthcare Products Regulatory Agency (UK MHRA) for Good Distribution Practice (GDP).

The award was granted by UK MHRA after dnata completed the Good Distribution Program, along with investing in state-of-the-art technology and infrastructure for pharma handling at many of their facilities.

The company’s investment included a high-tech warehouse monitoring system that operates 24 hours a day. The system is able to carry out temperature mapping and warn dnata operators ahead of any deviation in temperature that could potentially have a detrimental effect on the goods.

The warning allows operators to act in a proactive manner with a quick response to any adverse weather conditions that could lead to alternative transport routes for pharma products.

This new technology proved its worth recently when a severe cold front hit the UK and temperatures across the country plummeted. The company was well prepared for such a drastic change in temperature and ensured all pharmaceuticals handled followed the optimum route limiting the possibility of spoilage.

dnata was required to make enhancements to their quality processes, facilities management and operations documentation before they could be a candidate for certification. The process normally takes 12 to 24-months, dnata completed the requirements in under six months.

UK CEO for dnata, Gary Morgan said, “We have invested in pharma-handling facilities across the UK in response to customer demand and in recognition of the growing importance of pharma cold-chain logistics,”

Further adding, “With world-class technology already in place at our facilities, the next logical step was to ensure standards compliance and achieve UK MHRA certification.  These initiatives not only demonstrate our ongoing focus on safety and quality but also reinforce our commitment to our airline customers who operate in the fast-growing pharmaceutical transportation sector.”